CINCINNATI, June 3 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced it is ranked a top CRO to work with in the 2010 CenterWatch European Investigative Site Survey. Kendle is the only CRO to be ranked consistently among the top three providers for each of the past four years in the annual U.S. and European site surveys conducted by CenterWatch, a leading publishing and information services company focusing on the clinical trials industry. In the 2010 survey of investigative sites across 30 European countries Kendle was rated a top-three CRO on 21 of the 29 individual survey attributes and in particular ranked highly in the study initiation category, receiving the highest percentage of "excellent" ratings for its protocol design (48.5 percent) and for protocols aligning scientific rationale with clinical practice realities (50 percent).
"Kendle's ability to forge strong and collaborative relationships with investigative sites across the globe is key to our ability to deliver studies more efficiently and cost effectively for our customers, which is increasingly important in today's environment," said Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer. "Our continued recognition as a top-rated CRO and the fact that we are the only CRO to have been ranked consistently among the top three providers since 2007 is a further testament to our ability to build long-lasting and successful site relationships in support of our customers' needs."
In the 2010 European Investigative Site Survey, 76.1 percent of sites rated Kendle "Good" or "Excellent" for overall relationship quality. In addi
|SOURCE Kendle International Inc.|
Copyright©2010 PR Newswire.
All rights reserved